Page last updated: 2024-11-02

pilsicainide and Genetic Predisposition

pilsicainide has been researched along with Genetic Predisposition in 1 studies

pilsicainide: structure given in first source
pilsicainide : A secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker which is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ogawa, R1
Kishi, R1
Takagi, A1
Sakaue, I1
Takahashi, H1
Matsumoto, N1
Masuhara, K1
Nakazawa, K1
Kobayashi, S1
Miyake, F1
Echizen, H1

Other Studies

1 other study available for pilsicainide and Genetic Predisposition

ArticleYear
A novel microsatellite polymorphism of sodium channel beta1-subunit gene (SCN1B) may underlie abnormal cardiac excitation manifested by coved-type ST-elevation compatible with Brugada syndrome in Japanese.
    International journal of clinical pharmacology and therapeutics, 2010, Volume: 48, Issue:2

    Topics: Adult; Age Factors; Aged; Asian People; Brugada Syndrome; Electrocardiography; Female; Genetic Predi

2010